<?xml version="1.0" encoding="UTF-8"?>
<p id="p0355">Modern pharmacological studies supported the broad pharmacological effects of AR on various diseases. The pharmacological activities of 
 <italic>A. lancea</italic> have previously been reviewed (
 <xref rid="bib44" ref-type="bibr">Jun et al., 2018</xref>; 
 <xref rid="bib56" ref-type="bibr">Koonrungsesomboon et al., 2014</xref>). In vitro or vivo studies on animal models demonstrated promising activities of the crude extracts (ethanolic, water, benzene, and methanol) of 
 <italic>A. lancea</italic> and its major constituents (Î²-eudesmol, atractylodin, atractylon, and hinesol) on cancers, inflammation, fever and pain, gastrointestinal system, nervous system, cardiovascular system, and various microorganisms (
 <italic>Staphylococcus aureus</italic>, 
 <italic>E. coli</italic>, 
 <italic>C. albicans</italic>, 
 <italic>Saccharomyces cerevisiae</italic> and 
 <italic>Rhodotorula glutinis</italic>). The pharmacological activities of AR and its constituents on the gastrointestinal system (delay of gastric emptying, stimulation of intestinal motility, inhibition of gastric secretion, and antiulcer property) strongly supported their clinical use for the alleviation of digestive symptoms in traditional medicine (
 <xref rid="bib52" ref-type="bibr">Kimura and Sumiyoshi, 2012</xref>; 
 <xref rid="bib84" ref-type="bibr">Plengsuriyakarn et al., 2012</xref>).
</p>
